CAS: 10563-23-2; N1-Ethylpropane-1,3-Diamine

该化合物是一种有机化合物,其特征为脂态矿体结构,具有两种矿物质(-NH2)和氮原子的乙基替代物,有助于将其分类为二亚胺;该化合物一般是无色的,可粉黄液,具有强效的颗粒味;在水和各种有机溶剂中溶解,这增强了其在化学合成中的用途,并成为生产药物和农用化学化学品的一个构件;N-Ethyl-1,3-丙烷胺由于有矿组织,具有基本特性,允许其参与各种化学反应,包括核循环替代和凝聚反应;此外,该化合物可形成酸盐,在不同的应用中有用;安全考虑包括它有可能对皮肤和眼睛造成刺激,因此有必要采取适当的处理和储存措施;

结构式图片

相似化合物

13910-48-0 10239-34-6 273409-54-4

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

3-ethylamino propionitrile N-(3-benzylaminopropyl)-N'-(3-ethylaminopropyl)butane-1,4-diamine 1,N12-diethylspermineN1,N12-diethylspermine1-(3-Ethylamino-propylamino)-5,6,11-trimethyl-6H-pyrido[4,3-b]carbazol-9-ol N-ethyl-N'-(9-methoxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazol-1-yl)-propane-1,3-diamine N,N'-bis(mesitylenesulfonyl)-N-ethyl-1,3-diaminopropane cyclopentyl-hydroxy-phenyl-acetic acid-(1-ethyl-1,4,5,6-tetrahydro-pyrimidin-2-ylmethyl ester); hydr°Chloride

合成工艺路线路线简述

  • 合成目标产物 N-Ethyl-1,3-Propanediamine 主要起始原料 3-(Ethylamino)Propionitrile
  • (文献来源)合成步骤主要原料 3-(Ethylamino)Propionitrile
3-乙胺基丙腈置于镍 氢气体系中,用 乙醇,氨 用作溶剂,化学反应生成N-乙基-1,3-丙二胺
参考文献:Thuillier,G. Et Al.,Bulletin De La Societe Chimique De France,1963,P. 1087-1090
标题:Thuillier,G. Et Al.,Bulletin De La Societe Chimique De France,1963,P. 1087-1090

专利信息


专利号:US-9738647-B2
优先权日:2009-12-24
标题:Methods for the synthesis of polycyclic guanidine compounds
发明人:GRIDNEV ALEXEI
权利人:NOVOMER INC; SAUDI ARAMCO TECH CO
摘要:The present invention provides methods for the synthesis of polycyclic guanidine compounds. In certain embodiments, provided methods include the step of contacting a described reagent with a triamine compound to provide a polycyclic guanidine compound.

专利号:US-7834174-B2
优先权日:2004-09-10
标 题 :Per-6-guanidino-, alkylamino-cyclodextrins, methods of their synthesis and their use for the compaction of DNA and intercellular delivery
发明人:MAVRIDIS IRENE M; YANNAKOPOULOU KONSTANTINA; ELIADOU KYRIAKI; MOURTZIS NIKOLAOS; AGGELIDOU CHRYSI
权利人:MAVRIDIS IRENE M; YANNAKOPOULOU KONSTANTINA; ELIADOU KYRIAKI; MOURTZIS NIKOLAOS; AGGELIDOU CHRYSI
摘要:The invention relates to new compounds of type hexakis(6-deoxy-6-NH(CH 2 ) n —R 1 )α-cyclodextrin and heptakis(6-deoxy-6-NH(CH 2 ) n —R 1 )-(β-cyclodextrin, and octakis(6-deoxy-6-NH(CH 2 ) n —R 1 )-γ-cyclodextrin, where n=2-6 when R 1 =NH 2 and n=0 when R 1 =C(â•?NH)NH 2 and n=2-6 when R 1 =NH—C(â•?NH)NH 2 and their use in the compaction of DNA and in cell permeation. The invention also relates to methods of synthesis of the above compounds.

专利号:EP-1567195-B1
优先权日:2002-11-26
标题 :Dendrimer conjugates for selective solubilisation of protein aggregates
发明人:HEEGAARD PETER; BOAS ULRIK
权利人:UPFRONT CHROMATOGRAPHY AS
摘要:Dendrimer conjugates are presented, which are formed between a dendrimer and a protein solubilising substance. Such dendrimer conjugates ar effective in the treatment of protein aggregate-related diseases (e.g. prion-related diseases). The protein solubilising substance and the dendrimer together show a protein aggregate solubilising effect higher than a physical mixture of the dendrimer and the protein solubilising substance (i.e. a synergistic effect). Such dendrimer conjugates are useful in the treatment or prevention of protein aggregate-relates diseases, in disinfection/decontamination processes and in classifying or identifying protein aggregates. The synthesis of such dendrimer conjugates from readily-available starting materials is described.

专利号:US-2009111737-A1
优先权日:1999-05-24
标题:Novel antibacterial agents
发明人:CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
权利人:CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
摘要:This invention relates to novel multibinding compounds (agents) that are antibacterial agents. The multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands in their monovalent (i.e., unlinked) state have the ability to bind to a an enzyme involved in cell wall biosynthesis and metabolism, a precursor used in the synthesis of the bacterial cell wall and/or the bacterial cell surface thereby interfere with the synthesis and/or metabolism of the cell wall. In particular the multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands hasn a ligand domain capable of binding to penicillin binding proteins, a transpeptidase enzyme, a substrate of a transpeptidase enzyme, a beta-lactamase enzyme, pencillinase enzyme, cephalosporinase enzyme, a transglycoslase enzyme, or a transglycosylase enzyme substrate; Preferably, the ligands are selected from the beta lactam or glycopeptide class of antibacterial agents.

专利号:WO-2019013789-A1
优先权日:2017-07-12
标 题 :ANTIMICROBIAL COMPOUNDS
发明人:REDDY HARIPRASADA R KANNA; SEBAHAR PAUL R; SERRANO CATHERINE M; LOOPER RYAN E
权利人:CURZA GLOBAL LLC; THE UNIV OF UTAH RESEARCH FOUNDATION
摘要:The invention relates to compounds of formula I or their pharmaceutically acceptable salts. The compounds of formula I are antimicrobial agents which inhibit, for example, Mycobacterium tuberculosis (Mtb) H37Ra. The compounds of formula I also have anti-tuberculous activity, exhibit limited cytotoxicity and inhibit protein synthesis. The invention also relates to methods of making compounds of formula I, as well as methods of using compounds of formula I for the treatment of bacterial infections, particularly tuberculosis.

专利号:WO-2019013790-A1
优先权日:2017-07-12
标题:ANTIMICROBIAL COMPOUNDS AND USES THEREOF
发明人:REDDY HARIPRASADA; SEBAHAR PAUL; LOOPER RYAN
权利人:CURZA GLOBAL LLC; THE UNIV OF UTAH RESEARCH FOUNDATION
摘要:The invention relates to compounds of formula I: or pharmaceutically acceptable salts thereof. The compounds of formula I are antimicrobial agents which inhibit, for example, Mycobacterium tuberculosis (Mtb) H37Ra. The compounds of formula I also have anti-tuberculous activity, exhibiting limited cytotoxicity, and inhibiting protein synthesis. The invention also relates to methods of making compounds of Formula I, as well as methods of using the compounds of Formula I for the treatment of bacterial infections, particularly tuberculosis.
山东西亚化学有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.xiyashiji.com
企业联系电话:400-990-3999👤
📞山东西亚化学有限公司 ⚠️参考联系方式
联系人:徐雪
电话:400-990-3999
手机:13395398332
传真:0539-6365991
邮箱:3007715518@qq.com
通信地址: 临沭经济开发区化工园区(厂址)
邮编: 276000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:临沭经济开发区化工园区(厂址)
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1016/j.jpba.2008.02.019
摘要:Häkkinen MR, Keinänen TA, Vepsäläinen J, Khomutov AR, Alhonen L, Jänne J, Auriola S. Quantitative determination of underivatized polyamines by using isotope dilution RP-LC–ESI-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 2008 Sep;48(2):414–21. doi: 10.1016/j.jpba.2008.02.019.
参考文献:10.1007/s00726-009-0429-2
摘要:Häkkinen MR, Hyvönen MT, Auriola S, Casero RA, Vepsäläinen J, Khomutov AR, Alhonen L, Keinänen TA. Metabolism of N-alkylated spermine analogues by polyamine and spermine oxidases. Amino Acids. 2009 Dec 10;38(2):369–81. doi: 10.1007/s00726-009-0429-2.
摘要:Schantl, J. G., Science of Synthesis, (2006) 24, 226.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知